Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults - Takeaways - MDSpire

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults

  • By

  • Hasan Symum

  • Brooke Hoots

  • Harvey W. Kaufman

  • William A. Meyer

  • Ademola Osinubi

  • Andrew Kress

  • William W. Thompson

  • Carolyn Wester

  • July 6, 2026

  • 0 min

Share

  • 1

    Untreated hepatitis C virus can lead to severe health complications, but direct-acting antivirals cure over 95% of cases.

  • 2

    The study analyzed hepatitis C care outcomes among insured adults using the HealthVerity database from January 2019 to June 2022.

  • 3

    Of 91,491 adults with HCV, 62% had initial infection, 39.9% achieved viral clearance, and 35.7% initiated treatment.

  • 4

    Follow-up HCV RNA testing was limited, with 38.3% of individuals with initial infection lacking subsequent tests for viral clearance.

  • 5

    The study highlights the need for improved follow-up testing and data integration to enhance hepatitis C treatment monitoring.

Original Source(s)

Comparison of Care Cascade Outcome Measures for Hepatitis C Among Insured US Adults

  • by Hasan Symum, Brooke Hoots, Harvey W. Kaufman, William A. Meyer, Ademola Osinubi, Andrew Kress, William W. Thompson, Carolyn Wester

  • July 6, 2026

Related Content

Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies

Routine vs. Risk-Based Vaccination

The CDC has dropped routine recommendations for six childhood vaccines, shifting decisions to parents and doctors despite decades of evidence showing the shots prevented millions of hospitalizations and tens of thousands of deaths.

Testing for Sexually Transmitted and Bloodborne Infections in Substance Users: Insights from the 2023 British Columbia Harm Reduction Client Survey